nivolumab
bms
['checkmate274', 'nivo', 'nivolumab', 'check,mate,274']
tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase 3 #checkmate274 trial. presentation by . #esmo22 written coverage by on urotoday &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology